Podcast
Questions and Answers
What conclusion was drawn about the safety profiles of the two treatment groups?
What conclusion was drawn about the safety profiles of the two treatment groups?
- HP had a significantly higher risk of complications.
- Complications were comparable between groups. (correct)
- Safety profiles were not discussed.
- G + T had a significantly lower risk of complications.
What is the first step in the process of applying HEMOBLAST™ for bleeding control?
What is the first step in the process of applying HEMOBLAST™ for bleeding control?
- Irrigate excess powder after achieving hemostasis.
- Blot excess blood from the target bleeding site. (correct)
- Apply HEMOBLAST™ Bellows to the bleeding site.
- Hold a soaked laparotomy pad/gauze for 3 minutes.
How long should the soaked laparotomy pad/gauze be held in place to apply pressure?
How long should the soaked laparotomy pad/gauze be held in place to apply pressure?
- 3 minutes (correct)
- 5 minutes
- 1 minute
- 10 minutes
What should you do to the wound after achieving hemostasis?
What should you do to the wound after achieving hemostasis?
What needs to be done with HEMOBLAST™ Bellows before applying?
What needs to be done with HEMOBLAST™ Bellows before applying?
What is essential about the surface of the wound before applying HEMOBLAST™?
What is essential about the surface of the wound before applying HEMOBLAST™?
What is the maximum amount of thrombin contained in the HEMOBLAST™ Bellows?
What is the maximum amount of thrombin contained in the HEMOBLAST™ Bellows?
Which of the following is true regarding the HEMOBLAST™ Bellows Laparoscopic Applicator?
Which of the following is true regarding the HEMOBLAST™ Bellows Laparoscopic Applicator?
What is a notable characteristic of the HEMOBLAST™ Bellows regarding its safety profile?
What is a notable characteristic of the HEMOBLAST™ Bellows regarding its safety profile?
What is the purpose of the 10 cm nozzle extension provided with the HEMOBLAST™ Bellows?
What is the purpose of the 10 cm nozzle extension provided with the HEMOBLAST™ Bellows?
What is required to use the HEMOBLAST™ Bellows according to federal regulations?
What is required to use the HEMOBLAST™ Bellows according to federal regulations?
What is the minimum order quantity for the HEMOBLAST™ Bellows?
What is the minimum order quantity for the HEMOBLAST™ Bellows?
Which feature of the HEMOBLAST™ Bellows contributes to its biocompatibility?
Which feature of the HEMOBLAST™ Bellows contributes to its biocompatibility?
How is the HEMOBLAST™ Bellows Laparoscopic Applicator packaged?
How is the HEMOBLAST™ Bellows Laparoscopic Applicator packaged?
What type of bleeding is HEMOBLAST™ Bellows indicated for?
What type of bleeding is HEMOBLAST™ Bellows indicated for?
Which product is specifically stated as suitable for adjunct to hemostasis for minimal bleeding?
Which product is specifically stated as suitable for adjunct to hemostasis for minimal bleeding?
Which product is indicated for adjunctive hemostasis of capillary and small artery bleeding?
Which product is indicated for adjunctive hemostasis of capillary and small artery bleeding?
Which type of bleeding does NOT fall under the category treated by HEMOBLAST™ Bellows?
Which type of bleeding does NOT fall under the category treated by HEMOBLAST™ Bellows?
What is a characteristic of the products indicated for adjunctive hemostasis?
What is a characteristic of the products indicated for adjunctive hemostasis?
Flashcards are hidden until you start studying
Study Notes
HEMOBLAST™ Bellows Overview
- HEMOBLAST™ Bellows comes preloaded with 1.65 g of powder, containing a maximum of 1,500 units of thrombin.
- Includes a 10 cm nozzle extension for better application reach in open surgical procedures.
- Biocompatible and non-pyrogenic, suitable for medical use.
Application Features
- Designed for delivering hemostatic powder to actively bleeding sites during surgery.
- Compatible with trocars that are 5 mm in diameter or larger.
- Sold separately from the HEMOBLAST™ Bellows product.
Ordering Information
- HEMOBLAST™ Bellows and a 10 cm Nozzle Extension available as a case of 12 units.
- Laparoscopic Applicator also sold as an individually packaged unit, minimum order of 12 units.
- Clinical evaluation requests can be made via phone or email.
Caution and Risks
- Federal regulations mandate that this device is sold by or on the order of a physician.
- Injection into vessels or tissues is prohibited due to risks of allergic reactions and thromboembolic events, which could be life-threatening.
Application Steps
- Prepare the Site: Blot excess blood from the bleeding site to ensure the surface is dry.
- Apply Powder: Compress the bellows to apply sufficient hemostatic powder over the bleeding source.
- Use Pressure: Apply appropriate pressure with a soaked laparotomy pad/gauze for approximately three minutes.
- Inspect and Irrigate: Once hemostasis is achieved, gently irrigate away excess powder not part of the clot.
Bleeding Indications
- HEMOBLAST™ Bellows is uniquely indicated for minimal, mild, and moderate bleeding, applicable based on the SPOT GRADE™ (Surface Bleeding Severity Scale).
- Bleeding severity definition:
- Minimal: Oozing
- Mild: Pooling
- Moderate: Flowing
Comparison with Other Hemostatic Agents
- HEMOBLAST™ Bellows is positioned alongside other powdered hemostats and thrombin products.
- Competes with products like ARISTA™ AH, AVITENE™, SURGICEL®, among others, which are also used for adjunctive hemostasis in surgical scenarios.
Indications for Use
- Indicated as an adjunct to hemostasis in surgical procedures when conventional methods are ineffective, except for neurosurgical, ophthalmic, and urological applications.
- Note that traditional hemostatic agents are typically used for capillary, venous, and small arterial bleeding control during surgery.
Studying That Suits You
Use AI to generate personalized quizzes and flashcards to suit your learning preferences.
